| Gujarat Themis Biosyn Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 506879 |
NSE Symbol : GUJTHEM |
P/E(TTM) : 88.49 |
|
ISIN Demat : INE942C01045 |
Div & Yield% : 0.17 |
EPS(TTM) : 4.43 |
|
Book Value(₹) : 24.27 |
Market Cap(₹Cr) : 4,271.44 |
Face Value(₹) : 1.00 |
| Particulars | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 42.35 | 35.87 | 37.74 | 39.52 | 34.72 | 38.83 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 42.35 | 35.87 | 37.74 | 39.52 | 34.72 | 38.83 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 0.82 | 0.27 | 1.35 | 0.24 | 0.32 | 0.52 |
| Total Income | 43.17 | 36.15 | 39.08 | 39.76 | 35.04 | 39.35 |
| Total Expenditure | 21.41 | 21.95 | 21.70 | 20.65 | 19.33 | 20.28 |
| PBIDT | 21.76 | 14.20 | 17.39 | 19.11 | 15.71 | 19.07 |
| Interest | 0.04 | 0.04 | 0.07 | 0.14 | 0.08 | 0.07 |
| PBDT | 21.72 | 14.15 | 17.32 | 18.96 | 15.63 | 19.01 |
| Depreciation | 2.96 | 2.03 | 1.23 | 1.56 | 1.44 | 1.15 |
| Tax | 3.08 | 2.47 | 3.86 | 4.44 | 3.62 | 4.57 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 1.41 | 0.59 | 0.23 | -0.01 | 0.01 | 0.05 |
| Reported Profit After Tax | 14.26 | 9.06 | 12.00 | 12.97 | 10.57 | 13.24 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 14.26 | 9.06 | 12.00 | 12.97 | 10.57 | 13.24 |
| EPS (Unit Curr.) | 1.31 | 0.83 | 1.10 | 1.19 | 0.97 | 1.82 |
| EPS (Adj) (Unit Curr.) | 1.31 | 0.83 | 1.10 | 1.19 | 0.97 | 1.21 |
| Calculated EPS (Unit Curr.) | 1.31 | 0.83 | 1.10 | 1.19 | 0.97 | 1.82 |
| Calculated EPS (Adj) (Unit Curr.) | 1.31 | 0.83 | 1.10 | 1.19 | 0.97 | 1.21 |
| Calculated EPS (Ann.) (Unit Curr.) | 5.24 | 3.33 | 4.40 | 4.76 | 3.88 | 7.29 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 5.24 | 3.33 | 4.40 | 4.76 | 3.88 | 4.86 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 10.90 | 10.90 | 10.90 | 10.90 | 10.90 | 7.26 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 51.38 | 39.59 | 46.08 | 48.36 | 45.25 | 49.11 |
| PBDTM(%) | 51.29 | 39.45 | 45.89 | 47.98 | 45.02 | 48.96 |
| PATM(%) | 33.67 | 25.26 | 31.80 | 32.82 | 30.44 | 34.10 |